Clinical trial watch

June 1, 2011

This list of US-based National Institutes of Health trials is derived from the NIH database and includes US phase III and IV clinical trials that are currently recruiting female participants.

This list of US-based National Institutes of Health trials is derived from the NIH database and includes US phase III and IV clinical trials that are currently recruiting female participants. For information, view the complete database at http://ClinicalTrials.gov/.

Breast Cancer

• Combination Chemotherapy Followed By Doce-taxel or Ixabepilone in Treating Patients Who Have Undergone Surgery for Nonmetastatic Breast CancerSPONSORS: Federation Nationale des Centres de Lutte Contre le Cancer, National Cancer Institute
IDENTIFIER: NCT00630032

• Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy (2009-APBI)SPONSOR: Rocky Mountain Cancer Centers
IDENTIFIER: NCT01185132

• Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer (PT-304)SPONSORS: Precision Therapeutics, Department of Defense
IDENTIFIER: NCT01007890

• ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063DSPONSORS: GlaxoSmithKline, North Central Cancer Treatment Group, National Cancer Institute, Breast International Group, NCIC Clinical Trials Group
IDENTIFIER: NCT00490139

• Evaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast CancerSPONSOR: Emory University
IDENTIFIER: NCT01271738

• An Open-Label Study of Trastuzumab-MCC-DM1 (T-DM1) vs. Capecitabine + Lapatinib in Patients With HER2-Positive Locally Advanced or Metastatic Breast Cancer (EMILIA)SPONSORS: Genentech, Roche Pharma AG
IDENTIFIER: NCT00829166

• A Study of Trastuzumab-DM1 Plus Pertuzumab Versus Trastuzumab [Herceptin] Plus a Taxane in Patients With Metastatic Breast Cancer (MARIANNE)SPONSORS: Hoffmann-La Roche, Genentech
IDENTIFIER: NCT01120184